Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
After a maximum 12-week screening phase, an anticipated 1840 patients in each trial are randomized (1:1) to semaglutide or placebo for 156 weeks (104-week main treatment phase and 52-week extension)
Once an individual stops taking Semaglutide GLP-1, it is possible that they may regain some or all of the weight lost during the treatment
E., Dong, E
You should promptly contact your doctor if you experience severe or persistent side effects such as intense nausea, vomiting, or diarrhea that do not improve over time
US$ 28.31
US$ 23.05
US$ 29.03
